Virtus Fund Advisers’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$63.2K Sell
2,954
-502
-15% -$12.2K 0.2% 50
2024
Q3
$108K Hold
3,456
0.44% 24
2024
Q2
$53.7K Buy
3,456
+213
+7% +$2.58K 0.21% 53
2024
Q1
$34.3K Hold
3,243
0.12% 83
2023
Q4
$38.9K Buy
+3,243
New +$26.6K 0.24% 60

Other funds holding CDNA

Virtus Fund Advisers's CDNA Position: Q4 2024 in Review

Virtus Fund Advisers reduced its CareDx (CDNA) stake by 15% in Q4 2024, selling an estimated $12.2K and leaving 2,954 shares worth $63.2K. The position accounts for 0.2% of the portfolio, ranked #50.

Virtus Fund Advisers first reported a position in CDNA in Q4 2023 and has held it in 5 quarters since. The position peaked at $108K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Virtus Fund Advisers held 2,954 shares of CareDx worth $63.2K as of Q4 2024.
  • Virtus Fund Advisers sold 502 CareDx shares in Q4 2024, an estimated $12.2K.
  • CareDx made up 0.2% of Virtus Fund Advisers's portfolio in Q4 2024, its #50 holding.
  • Virtus Fund Advisers first reported a position in CareDx in Q4 2023 and has held it in 5 quarters since.
  • Virtus Fund Advisers's CareDx position peaked at $108K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.